Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure

Overview of attention for article published in Frontiers in Pharmacology, June 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

policy: 2 policy sources

twitter: 8 X users

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 65 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

Study on best practices in the public procurement of medicines . Annex 4, PPM country fiches

Cited by The Publications Office of the European Union on 19 Dec 2023

The Publications Office of the European Union (Publications Office), based in Luxembourg, is an interinstitutional office whose task is to publish the publications of the institutions of the European Union.

Study on best practices in the public procurement of medicines . Annex 4, PPM country fiches

Cited by The Publications Office of the European Union on 05 Jun 2023

Payer policies to support innovation and access to medicines in the WHO European Region

Cited by World Health Organization on 25 Aug 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Payer policies to support innovation and access to medicines in the WHO European Region

Cited by World Health Organization on 01 Jan 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.